Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PURSUIT-J: Golimumab in Japanese UC Patients
NCT01863771Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2013
- Primary completion
- Jan 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of golimumab in ulcerative colitis (UC), sponsored by Janssen Pharmaceutical. Started Mar 2013; status: completed.
02
Drugs
golimumab
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT01863771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863771.